Evaluation of Functionally Meaningful Measures for Clinical Trials of Cognition Enhancement in Schizophrenia

F. Green, Michael; R. Schooler, Nina; S Kern, Robert; Frese, Fred; Granberry, Wendy; D. Harvey, Philip; N. Karson, Craig; M Peters, Nancy; Stewart, Michelle; J. Seidman, Larry; Sonnenberg, John; S. Stone, William; P. Walling, David; Stover, Ellen; R. Marder, Stephen

doi:10.1176/appi.ajp.2010.10030414

Public

Evaluation of Functionally Meaningful Measures for Clinical Trials of Cognition Enhancement in Schizophrenia

Published in American Journal of Psychiatry • Feb 2, 2011

Authors:

Michael F. Green

Nina R. Schooler

Robert S Kern

Abstract

OBJECTIVE: Because reduction of psychotic symptoms in schizophrenia does not result in adequate community functioning, efforts have shifted to other areas, such as cognitive impairment. The U.S. Food and Drug Administration requires that drugs for cognition enhancement in schizophrenia show improvem...

Subject

Cognition

Schizophrenia (object-oriented programming)

Psychology

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!